Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A van Doorn

Showing results (11-20 of 163) with videos related to

Pageof 17
Sort By:
Annals of Neurology|May 1, 1995
Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapiesF G van der Meché, P A van Doorn
Handbook of Clinical Neurology|September 18, 2016
Peripheral neuropathiesR Hanewinckel, M A Ikram, P A Van Doorn
Electroencephalography and Clinical Neurophysiology. Supplement|February 26, 2000
Chronic inflammatory demyelinating polyneuropathy (CIDP)F G Van der Meché, P A Van Doorn
Neurology|November 23, 2000
IVIg treatment improves multifocal motor neuropathy: easy to start but difficult to stopP A van Doorn, F G van der Meché
Muscle & Nerve|February 1, 1997
The current place of high-dose immunoglobulins in the treatment of neuromuscular disordersF G van der Meché, P A van Doorn
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1997
Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy: a pilot studyD S Molenaar, P A van Doorn, M Vermeulen
Clinical Immunology and Immunopathology|June 1, 1993
Spontaneous recovery from the Guillain-Barré syndrome is associated with anti-idiotypic antibodies recognizing a cross-reactive idiotype on anti-neuroblastoma cell line antibodiesI Lundkvist, P A van Doorn, M Vermeulen, et al.
The Cochrane Database of Systematic Reviews|January 22, 2003
Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathyR A Hughes, A V Swan, P A van Doorn
Lancet (London, England)|August 31, 1996
Improvement of stiff-man syndrome with vigabatrinF H Vermeij, P A van Doorn, H F Busch
Neurology|April 30, 2010
Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective studyL Ruts, J Drenthen, B C Jacobs, et al.
Pageof 17

Showing results (11-20 of 163) with videos related to

Sort By:
Pageof 17
Annals of Neurology|May 1, 1995
Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapiesF G van der Meché, P A van Doorn
Handbook of Clinical Neurology|September 18, 2016
Peripheral neuropathiesR Hanewinckel, M A Ikram, P A Van Doorn
Electroencephalography and Clinical Neurophysiology. Supplement|February 26, 2000
Chronic inflammatory demyelinating polyneuropathy (CIDP)F G Van der Meché, P A Van Doorn
Neurology|November 23, 2000
IVIg treatment improves multifocal motor neuropathy: easy to start but difficult to stopP A van Doorn, F G van der Meché
Muscle & Nerve|February 1, 1997
The current place of high-dose immunoglobulins in the treatment of neuromuscular disordersF G van der Meché, P A van Doorn
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1997
Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy: a pilot studyD S Molenaar, P A van Doorn, M Vermeulen
Clinical Immunology and Immunopathology|June 1, 1993
Spontaneous recovery from the Guillain-Barré syndrome is associated with anti-idiotypic antibodies recognizing a cross-reactive idiotype on anti-neuroblastoma cell line antibodiesI Lundkvist, P A van Doorn, M Vermeulen, et al.
The Cochrane Database of Systematic Reviews|January 22, 2003
Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathyR A Hughes, A V Swan, P A van Doorn
Lancet (London, England)|August 31, 1996
Improvement of stiff-man syndrome with vigabatrinF H Vermeij, P A van Doorn, H F Busch
Neurology|April 30, 2010
Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective studyL Ruts, J Drenthen, B C Jacobs, et al.
Pageof 17